Tert-butylhydroquinone ameliorates doxorubicin-induced cardiotoxicity by activating Nrf2 and inducing the expression of its target genes.

Linfeng Wang(Second Affiliated Hospital of Jilin University), Huicai Guo(Hebei Medical University), Suwen Su(Hebei Medical University), Yi Liu(University of Maryland, College Park), Guoqiang Zhang(Hebei Medical University), Yujie Niu(Hebei Medical University), Lei Wang(Xijing Hospital), Rong Zhang(Chinese PLA General Hospital), Yansu Guo(Capital Medical University), Chunyan Li(First Affiliated Hospital of Guangzhou Medical University), Wenbo Jiang(Xihua University)
PubMed
January 1, 2015
Cited by 34


Related Papers